honokiol has been researched along with Esophageal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ajani, JA; Chen, G; Demizu, Y; Guha, S; Huang, P; Hung, MC; Izzo, J; Wang, F; Wu, X | 1 |
| Arbiser, JL; Cheng, E; Huo, X; Souza, RF; Spechler, SJ; Wang, DH; Yu, C; Zhang, HY; Zhang, Q; Zhang, X | 1 |
2 other study(ies) available for honokiol and Esophageal Neoplasms
| Article | Year |
|---|---|
Different redox states in malignant and nonmalignant esophageal epithelial cells and differential cytotoxic responses to bile acid and honokiol.
Topics: Adenocarcinoma; Base Sequence; Bile Acids and Salts; Biphenyl Compounds; Cell Line, Transformed; Cyclophilins; Epithelial Cells; Esophageal Neoplasms; Esophagus; Humans; Lignans; Oxidation-Reduction; Peptidyl-Prolyl Isomerase F; RNA, Small Interfering | 2009 |
Targeting the intrinsic inflammatory pathway: honokiol exerts proapoptotic effects through STAT3 inhibition in transformed Barrett's cells.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Apoptosis; Barrett Esophagus; Biphenyl Compounds; Cell Line, Tumor; Cell Transformation, Neoplastic; Esophageal Neoplasms; Humans; Lignans; Signal Transduction; STAT3 Transcription Factor | 2012 |